Moreover, Dong et al. assessed TP53 mutations in 10 CLL patients before and after treatment and concluded that TP53 mutation could not be induced by chemotherapeutic agents [422]. The gene discussed is TP53; the disease is B-cell chronic lymphocytic leukemia.